About Abdi ibrahim pharmaceuticals
Abdi Ibrahim Pharmaceuticals: Turkey's Healing Power
Abdi Ibrahim Pharmaceuticals is a leading pharmaceutical company in Turkey that has been providing high-quality healthcare products for over 100 years. The company was founded in 1912 by Abdi İbrahim, a pharmacist who had a vision to improve the health and well-being of people in his community. Today, Abdi Ibrahim Pharmaceuticals is one of the largest pharmaceutical companies in Turkey and has expanded its operations to over 50 countries worldwide.
The company's mission is to provide innovative and effective healthcare solutions that improve the quality of life for patients. Abdi Ibrahim Pharmaceuticals focuses on research and development to create new drugs and treatments that address unmet medical needs. The company also invests heavily in manufacturing facilities, ensuring that its products are produced under strict quality control standards.
Abdi İbrahim İlaç offers a wide range of products across various therapeutic areas such as cardiology, neurology, gastroenterology, respiratory diseases, oncology, dermatology, urology & gynecology. Some of their popular brands include Clexane (enoxaparin), Ebrantil (nicardipine), Nootropil (piracetam), Tazocin (piperacillin/tazobactam) among others.
One area where Abdi Ibrahim Pharmaceuticals excels is biosimilars - biological medicines that are similar but not identical to an existing biologic drug. Biosimilars offer significant cost savings compared to their reference biologics while maintaining similar efficacy and safety profiles. Abdi İbrahim has developed several biosimilar drugs including Remsima (infliximab) which treats autoimmune diseases like rheumatoid arthritis or Crohn’s disease; Truxima (rituximab) used for cancer treatment; Solymbic®(adalimumab) used for treating inflammatory bowel disease(IBD).
In addition to developing innovative healthcare solutions, Abdi Ibrahim Pharmaceuticals also places great importance on corporate social responsibility initiatives aimed at improving public health outcomes across Turkey through various programs such as "Healthy Life with Pharmacy" which provides free health screenings at pharmacies nationwide.
The company's commitment towards sustainability can be seen through its efforts towards reducing carbon footprint by implementing energy-efficient technologies at production sites or using renewable energy sources wherever possible.
Abdulhamit Gulseren serves as CEO since 2019 after serving as CFO since 2008 he brings extensive experience from finance sector into his role as CEO with focus on digital transformation & innovation within the organization.
In conclusion,
Abdulhamit Gulseren said "Our goal is not only about being successful financially but also making sure we contribute positively towards society." With this mindset combined with their expertise in research & development along with manufacturing capabilities make them one of the most trusted names when it comes down delivering high-quality healthcare solutions globally while keeping patient safety at forefront always!